FDA Issues Guidance on Certain Ophthalmic Products: Policy for Compliance with 21 CFR Part 4
The U.S. Food and Drug Administration today issued the guidance for industry, Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4. This guidance provides information to...